News
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
We recently published a list of 10 Firms Drenched in Red Today. In this article, we are going to take a look at where Moderna ...
Moderna, Inc. (NASDAQ:MRNA) made a name for itself by quickly developing an effective coronavirus vaccine when the world needed it the most. However, the stock has largely struggled since the pandemic ...
Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the ...
Explore more
The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.
The FDA will make it more costly to seek approval of Covid-19 vaccines, but Moderna's shareholder reacted favorable to the ...
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.
Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, ...
Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results